InnovAge Holding Corp. Deferred Offering Costs
InnovAge Holding Corp. (INNV) had Deferred Offering Costs of $4.50 million as of 2021-03-09, per its 10-K filed 2022-09-13.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredOfferingCosts · last filed 2022-09-13
- 2021-03-09: Deferred Offering Costs $4.50M.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-03-09 | $4.50M 10-K · filed 2022-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |